[go: up one dir, main page]

PT920426E - Novos derivados de tiazole com efeito inibidor de fosfodiesterase - Google Patents

Novos derivados de tiazole com efeito inibidor de fosfodiesterase

Info

Publication number
PT920426E
PT920426E PT97940080T PT97940080T PT920426E PT 920426 E PT920426 E PT 920426E PT 97940080 T PT97940080 T PT 97940080T PT 97940080 T PT97940080 T PT 97940080T PT 920426 E PT920426 E PT 920426E
Authority
PT
Portugal
Prior art keywords
new
phosphodiesterase inhibitor
pct
inhibitor effect
tiazole
Prior art date
Application number
PT97940080T
Other languages
English (en)
Inventor
Rolf Beume
Dietrich Hafner
Hans-Peter Kley
Thomas Bar
Thomas Martin
Hildegard Boss
Dieter Flockerzi
Beate Schmidt
Armin Hatzelmann
Hermann Amschler
Ulrich Thibaut
Wolf-Rudiger Ulrich
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PT920426E publication Critical patent/PT920426E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT97940080T 1996-08-26 1997-08-13 Novos derivados de tiazole com efeito inibidor de fosfodiesterase PT920426E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19634411 1996-08-26
EP96113737 1996-08-28

Publications (1)

Publication Number Publication Date
PT920426E true PT920426E (pt) 2004-02-27

Family

ID=26028746

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97940080T PT920426E (pt) 1996-08-26 1997-08-13 Novos derivados de tiazole com efeito inibidor de fosfodiesterase

Country Status (12)

Country Link
US (1) US6011037A (pt)
EP (1) EP0920426B9 (pt)
JP (1) JP2000516940A (pt)
AT (1) ATE251153T1 (pt)
AU (1) AU4205197A (pt)
CY (1) CY2509B1 (pt)
DE (1) DE59710816D1 (pt)
DK (1) DK0920426T3 (pt)
ES (1) ES2208950T3 (pt)
PT (1) PT920426E (pt)
SI (1) SI0920426T1 (pt)
WO (1) WO1998008841A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287231B6 (sk) 1999-08-21 2010-04-07 Nycomed Gmbh Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
CA2451981C (en) 2001-08-13 2012-02-21 Janssen Pharmaceutica N.V. 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
AU2004226353A1 (en) 2003-04-01 2004-10-14 Laboratoires Serono Sa Inhibitors of phosphodiesterases in infertility
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス,インコーポレイティド 神経発生のgaba受容体媒介調節
WO2007104035A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) * 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
KR20090064418A (ko) * 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
WO2008036678A2 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2012154518A1 (en) 2011-05-10 2012-11-15 Merck Sharp & Dohme Corp. Bipyridylaminopyridines as syk inhibitors
WO2012154520A1 (en) 2011-05-10 2012-11-15 Merck Sharp & Dohme Corp. Pyridyl aminopyridines as syk inhibitors
KR20140028062A (ko) * 2011-05-10 2014-03-07 머크 샤프 앤드 돔 코포레이션 Syk 억제제로서의 아미노피리미딘
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
WO1993024472A1 (fr) * 1992-05-29 1993-12-09 Otsuka Pharmaceutical Co., Ltd. Derive de thiazole
GB9315017D0 (en) * 1993-07-20 1993-09-01 Glaxo Lab Sa Chemical compounds
JPH10504542A (ja) * 1994-07-27 1998-05-06 ジー.ディー.サール アンド カンパニー 炎症処置用の置換チアゾール化合物

Also Published As

Publication number Publication date
SI0920426T1 (en) 2004-04-30
EP0920426A1 (de) 1999-06-09
CY2509B1 (en) 2005-12-23
DE59710816D1 (de) 2003-11-06
ATE251153T1 (de) 2003-10-15
AU4205197A (en) 1998-03-19
ES2208950T3 (es) 2004-06-16
US6011037A (en) 2000-01-04
DK0920426T3 (da) 2004-02-02
WO1998008841A1 (de) 1998-03-05
EP0920426B9 (de) 2005-04-06
JP2000516940A (ja) 2000-12-19
EP0920426B1 (de) 2003-10-01

Similar Documents

Publication Publication Date Title
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
ATE233247T1 (de) Phtalazinonen
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
MX9700557A (es) Dihidrobenzofuranos.
DK1000035T3 (da) Substituerede 6-phenylphenanthridiner
ATE233252T1 (de) Substituierte dihydrobenzofurane als pde- hemmstoffe
IL122737A (en) Salts of amidine derivatives and cyclooxygenase inhibitors, their preparation and pharmaceutical compositions containing them
PT1003724E (pt) Derivados substituidos com accao antiviral
GB2324091B (en) Metalloproteinase inhibitors
SI0937075T1 (en) New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.